Association between metabolic syndrome and hepatitis B virus infection in the Roma population in Eastern Slovakia: A population-based study

Central European Journal of Public Health

Volumn 22, Issue , 2014, Pages S37-S42

  Janičko, Martin ^a   Senajová, Gabriela ^a   Dražilová, Sylvia ^b   Veselíny, Eduard ^a   Fedacko J ^a   Siegfried, Leonard ^a   Kristian, Pavol ^a   Virág, Ladislav ^a   Pella, Daniel ^a   Mareková, Mária ^a   Gecková, Andrea Madarasová ^c,d   Kalanin, Peter ^a   Jarčuška, Peter ^a   Halánová, Monika ^c   Jarèuška, Pavol ^e   Pastvová, Lýdia ^e   Kollárová, Jana ^e   Kolarèik, Peter ^e   Bobáková, Daniela ^e   Veselská, Zuzana ^e   Babinská, Ingrid ^e   Rosenberger, Jaroslav ^e   Schréter, Ivan ^e   Birková, Anna ^e   Marta, Kme’Ová ^e   Petrášová, Darina ^e   Cáriková, Katarína ^e   Lovayová, Viera ^e   Merkovská, Lucia ^e   Jedlièková, Lucia ^e   Valková, Ivana ^e   more..

^a Med Faculty of Safarik University   (Slovakia)

^b Department of Internal Medicine Poprad Hospital   (Slovakia)

^c P J AFÁRIK UNIVERSITY   (Slovakia)

^d PALACKÝ UNIVERSITY   (Czech Republic)

^e NONE

Author keywords

Apolipoprotein B100; Cholesterol; Chronic hepatitis B; HBV DNA; Metabolic syndrome

Indexed keywords

APOLIPOPROTEIN B100; BIOLOGICAL MARKER; CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BLOOD; COMORBIDITY; CROSS-SECTIONAL STUDY; ETHNOLOGY; FEMALE; HEALTH SURVEY; HEPATITIS B; HUMAN; MALE; METABOLIC SYNDROME X; METHODOLOGY; MIDDLE AGED; ROMANI (PEOPLE); RURAL POPULATION; SLOVAKIA; STATISTICS;

ADOLESCENT; ADULT; APOLIPOPROTEIN B-100; BIOLOGICAL MARKERS; CHOLESTEROL; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GYPSIES; HEALTH SURVEYS; HEPATITIS B; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RURAL POPULATION; SLOVAKIA; TRIGLYCERIDES;

EID: 84905109408     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: 10.21101/cejph.a3900     Document Type: Article

References (22)

1. Dallongeville J, Cottel D, Ferrières J, Arveiler D, Bingham A, Ruidavets JB, et al. Household income is associated with the risk of metabolic syndrome in a sex-specific manner. Diabetes Care. 2005 Feb;28(2):409-415.
2. Manuck SB, Phillips JE, Gianaros PJ, Flory JD, Muldoon MF. Subjective socioeconomic status and presence of the metabolic syndrome in midlife community volunteers. Psychosom Med. 2010 Jan;72(1):35-45.
3. Park MJ, Yun KE, Lee GE, Cho HJ, Park HS. A cross-sectional study of socioeconomic status and the metabolic syndrome in Korean adults. Ann Epidemiol. 2007 Apr;17(4):320-326.
4. Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond). 2008 Sep;115(5):141-150.
5. Pasquini P, Kahn HA, Pileggi D, Panà A, Terzi J, Guzzanti E. Prevalence of hepatitis B markers in Italy. Am J Epidemiol. 1983 Nov;118(5):699-709.
6. Zhang H, Li Q, Sun J, Wang C, Gu Q, Feng X, et al. Seroprevalence and risk factors for hepatitis B infection in an adult population in Northeast China. Int J Med Sci. 2011;8(4):321-331.
7. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al.; REVEAL-HBV Study Group. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006 Jan 4;295(1):65-73.
8. Wong GLH, Wong VWS, Choi PCL, Chan AWH, Chim AML, Yiu KKL, et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut. 2009 Jan;58(1):111-117.
9. Babinska I, Dankulincova Veselska Z, Bobakova D, Pella D, Panico S, Reijneveld SA, et al.; HEPA-META team. Is the cardiovascular risk profile of people living in Roma settlements worse in comparison with the majority population in Slovakia? Int J Public Health. 2013 Jun;58(3):417-425.
10. Madarasová Gecková A, Jarčuška P, Mareková M, Pella D, Siegfried L, Jarčuška P, et al.; HepaMeta Team. HepaMeta – Prevalence of hepatitis B/C and metabolic syndrome in population living in separated and segregated Roma settlements: a methodology for a cross-sectional population-based study using community-based approach. Cent Eur J Public Health. 2014 Mar;22 Suppl:S6-S11.
11. Nardone A, Anastassopoulou CG, Theeten H, Kriz B, Davidkin I, Thierfelder W, et al. A comparison of hepatitis B seroepidemiology in ten European countries. Epidemiol Infect. 2009 Jul;137(7):961-969.
12. Michos A, Terzidis A, Kalampoki V, Pantelakis K, Spanos T, Petridou ET. Seroprevalence and risk factors for hepatitis A, B, and C among Roma and non-Roma children in a deprived area of Athens, Greece. J Med Virol. 2008 May;80(5):791-797.
13. Bondini S, Kallman J, Wheeler A, Prakash S, Gramlich T, Jondle DM, et al. Impact of non-alcoholic fatty liver disease on chronic hepatitis B. Liver Int. 2007 Jun;27(5):607-611.
14. Luo B, Wang Y, Wang K. Association of metabolic syndrome and hepatitis B infection in a Chinese population. Clin Chim Acta. 2007 May 1;380(1-2):238-240.
15. Hsu CS, Liu CH, Wang CC, Tseng TC, Liu CJ, Chen CL, et al. Impact of hepatitis B virus infection on metabolic profiles and modifying factors. J Viral Hepat. 2012 Feb;19(2):e48-e57.
16. Hajjou M, Norel R, Carver R, Marion P, Cullen J, Rogler LE, et al. cDNA microarray analysis of HBV transgenic mouse liver identifies genes in lipid biosynthetic and growth control pathways affected by HBV. J Med Virol. 2005 Sep;77(1):57-65.
17. Yen SL, Chiu TY, Lin YC, Lee YC, Lee LT, Huang KC. Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen. Int J Obes (Lond). 2008 Mar;32(3):474-480.
18. Sun SS, Sabo R, Arslanian S, Wu R, Sabo C. Age variation and sexual dimorphism in the sixteen diagnostic clusters of risk factors for the metabolic syndrome. Z Gesundh Wiss. 2012 Oct;20(5):487-497.
19. Wang YY, Lin SY, Sheu WH, Liu PH, Tung KC. Obesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infection. Metabolism. 2010 Apr;59(4):486-491.
20. Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, et al. Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values. J Med Virol. 2010 Apr;82(4):539-545.
21. Zhao J, Zhao Y, Wang H, Gu X, Ji J, Gao C. Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study. Nutr J. 2011 May 15;10:49.
22. Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut. 2010 Oct;59(10):1410-1415.